Abiopharma

News list

Zhou Jiming 🟢 acquired 150.0K shares (1 derivative) of 20/20 Biolabs, Inc. (AIDX) at $1.88 Transaction Date: Apr 02, 2026 | Filing ID: 040581

Full text

News bot April 6, 2026, 9:56 p.m.
🔍 Zhou Jiming (Executive)

Company: 20/20 Biolabs, Inc. (AIDX)

Report Date: 2026-04-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 150,000
Detailed Transactions and Holdings:
- Acquired 150,000 shares of Stock Option at $1.88 per share (Derivative)
  Date: 2026-04-02 | Code: A | Expires: 2036-04-02 | Exercise: 2026-04-02 | equity_swap_involved: 0 | shares_owned_after: 150,000.00 | transaction_form_type: 4